Proleukin (Prometheus Laboratories Inc.)


Welcome to the PulseAid listing for the Proleukin drug offered from Prometheus Laboratories Inc.. This Increased Lymphocyte Activation [PE],Increased Lymphocyte Cell Production [PE],Interleukin-2 [Chemical/Ingredient],Lymphocyte Growth Factor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Prometheus Laboratories Inc.
NON-PROPRIETARY NAME: aldesleukin
SUBSTANCE NAME: ALDESLEUKIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Lymphocyte Activation [PE],Increased Lymphocyte Cell Production [PE],Interleukin-2 [Chemical/Ingredient],Lymphocyte Growth Factor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1992-05-05
END MARKETING DATE: 0000-00-00


Proleukin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionProleukin from Prometheus Laboratories Inc.
LABELER NAME: Prometheus Laboratories Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.1(mg/mL)
START MARKETING DATE: 1992-05-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65483-116_b3294680-603d-42f9-a4c9-473213f6797a
PRODUCT NDC: 65483-116
APPLICATION NUMBER: BLA103293

Other ALDESLEUKIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Guna spaGUNA-IL 2
Prometheus Laboratories Inc.Proleukin